Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2-breast cancer from the perspective of the Spanish health system

Colaboración

Año: 2025

Fenix-Caballero, S; Sanchez-Vegas, A; Del-Rey, EJA; Epstein, D; Garcia-Mochon, L; Lima, AOD

Título: EUROPEAN JOURNAL OF HEALTH ECONOMICS

• Q1